Life sciences and healthcare
Ministry of Health publishes internal regulations for the Ceis CD. The reformulation of the internal regulations of the CD and the CTA was determined by the TCU.
National Supplementary Health Agency (ANS) regulates regulatory sandbox: rule on discount cards may be the first object to be tested.
Brazilian Ministry of Health publishes internal regulations of the Technical Evaluation Commission (CTA) of the Brazilian Health Industrial Complex (Ceis).
ANS opens public consultation on regulatory sandbox to allow development of supplementary health solutions incompatible with current regulations.
National Supplementary Health Agency opens consultation on collective readjustment and outpatient plans. Contributions can be sent until October 31st.
Anvisa opens public consultation that proposes criteria and procedures for the signature of commitment terms for registration and post-registration of medicines.
Map opens public hearing on drone and manned operations, to adjust standards to new technologies and reduce bureaucracy.
In September, the Federal Supreme Court (STF) resumed the trial of two leading cases involving the supply of medicines.
Federal Council of Medicine (CFM) regulates the relationship between doctors and industry. New resolution comes into force in March 2025.
Federal Pharmacy Council regulates pharmaceutical practice in digital health and AI. New regulation allows the prescription of digital therapies.
Anvisa publishes notice for collecting contributions on the regulatory sandbox proposal. Public call of subsidies runs from August 12 to October 11.
Ebook: New rules for public private partnership under the Brazilian Health Industrial Complex (CEIS)
Our updated ebook New Rules for Private Partnerships under the Brazilian Health Industrial Complex (CEIS) details recent public policies issued by the Brazilian Ministry of Health for strengthening the Unified Health System (SUS) industry and innovation.
